Numerous pathological variants in GBA1 compromise the trafficking of hGCase from the ER to lysosomes [20–22], and decreased levels of lysosomal GCase has been proposed to contribute to PD risk [23, 24]. Here, GBA1 is linked to Parkinson disease.